sar425899 glp-1 glucagon dual agonist sanofi Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes - Cheang - 2018 - ChemMedChem Glucagon-like peptide 1 (GLP-1) -

Effects of creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin on the ultrastructure of normal skin-A pilot clinical, histologic, and ultrastructural study

Indications Eye Disorders The function of oxidative processes in diabetes, age-related macular degeneration (AMD), dry eye syndrome, and cataracts appear to be critical for the progression of pathological alterations in ocular tissues

Immunopharmacol Immunotoxicol 42:306313 Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

Franz 1993